E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER.
316.0K views | +117 today
E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER.

Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.

ESSAI
Your new post is loading...
Your new post is loading...
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 3:46 PM
Scoop.it!

Silicon Valley advisor: Mobile health winners will be those who help MDs

Silicon Valley advisor: Mobile health winners will be those who help MDs | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
“Ten years from now, we’ll be talking about behavioral change methods, not the technology.” That was a prediction Don Jones, vice president of global strategy and market development for Qualcomm Life, the healthcare connectivity division of San Diego-based...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health Care Business
October 8, 2013 3:27 PM
Scoop.it!

Disruptive technologies: Advances that will transform life, business, and the global economy | McKinsey & Company

Disruptive technologies: Advances that will transform life, business, and the global economy | McKinsey & Company | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Twelve emerging technologies—including the mobile Internet, autonomous vehicles, and advanced genomics—have the potential to truly reshape the world in which we live and work.

Via rob halkes
rob halkes's curator insight, July 31, 2013 5:03 AM

Great report and insights about the upcoming developments to social business, also in health care. Follow for instance the topic "the internet of things"..

It will not all be pleasant surprises and easy to go on developments. That's also the meaning of disruptive. For health care we need to care to adapt systems and developments in a constructive way: focusing on developments at the patient's side of care. By helping patients to adopt technologies and support them to adopt and adapt their behaviour, things might go more smoothly than just "disruptive".

The challenge for all involved has to do with the willingness and competence to work multidisciplinary together to design improved care processes and the very change process itself. "Traditional","hierarchical" thinking from an idea of dominance of medical theory, will not help.
Not to say, of course that medical knowledge should be aborted. Instead,  it will inspire new ways of developing therapies, along with social, informational, etc. and specifically behavioural sciences with insights from patients' behaviour.

It awaits to be seen how the professionals' attitude will be disruptive or facilitative ..

Rescooped by Lionel Reichardt / le Pharmageek from Pharmabook
October 8, 2013 2:56 PM
Scoop.it!

Adherence app MediSafe to boost medication adherence up to 81 percent

Adherence app MediSafe to boost medication adherence up to 81 percent | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

MediSafe is a cloud-based app system — the patients get a reminder to take their meds on their Android or Apple smartphone app, and are then prompted to record it if they do. If they don’t indicate that they’ve taken their dose, a graduated series of friends and family is informed and can take action.

“It pushes you a notification when its time to take your meds,” MediSafe CEO Omri “Bob” Shor told MobiHealthNews in January. “The first one is a quiet one, like a text message. The second one is a louder one. The third one you can’t ignore, and the fourth one goes to your wife.”

The company will use the money to build up strategic partnerships with pharma companies, pharmacies, HMOs, employers and hospitals. MediSafe hopes to be valuable to those stakeholders because it not only can increase patients’ medication adherence, but it also collects de-identified aggregate data about patients’ adherence.


Via Marc Phippen, Sam Stern, Philippe Loizon
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from mHealth- Advances, Knowledge and Patient Engagement
October 8, 2013 10:34 AM
Scoop.it!

Meaningful Use for Mobile Health

Meaningful Use for Mobile Health | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

“Stop reading this blog and look up. What do you see? I bet the majority of you, especially if you are in a public place, will see most people with their heads down looking at their cell phones (b...”


Via eMedToday
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digitized Health
October 8, 2013 9:13 AM
Scoop.it!

Diabetics Encouraged to Use New Social Media Platform Gluco-Share

Diabetics Encouraged to Use New Social Media Platform Gluco-Share | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
In the fight against diabetes, King’s Variety Stores – simply known as “King’s” in the company’s home state of Idaho -  has joined forces with the Madden Family in the launch of the new app Gluco-Share.

Via Emmanuel Capitaine
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital et santé
October 8, 2013 8:54 AM
Scoop.it!

Attention, les « applis » dermatologiques ne sont pas toutes fiables | Le Quotidien du Medecin

Attention, les « applis » dermatologiques ne sont pas toutes fiables | Le Quotidien du Medecin: http://t.co/kEWFa3FAwK

Via Agathe Quignot
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 8:52 AM
Scoop.it!

Applis à usage médical : des Français majoritairement favorables

Applis à usage médical : des Français majoritairement favorables | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
[Hôpital.fr] Les Français sont, en grande majorité, favorables aux nouvelles technologies en matière de santé ou de médecine.
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:37 AM
Scoop.it!

Conférence " Les enjeux de l'e-réputation pour les laboratoires pharmaceutiques" (with images, tweets) · lionelreichardt

#digimind - en tweets & pics - 03 octobre 2013 - Paris (“@LeemFrance: Les enjeux de l'#ereputation pour les labos #pharma par le pharmageek @LionelREICHARDT http://t.co/dg5psi8YA0”...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:30 AM
Scoop.it!

La carte qui va révolutionner votre façon de voir le monde Internet

La carte qui va révolutionner votre façon de voir le monde Internet | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Google et Facebook dominent largement le trafic Internet mondial…sauf en Chine et en Russie.
Google (rouge) et Facebook (bleu) dominent...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:28 AM
Scoop.it!

iHealth gets FDA clearance for medical-grade pulse ox

iHealth gets FDA clearance for medical-grade pulse ox | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
iHealth Labs, a subsidiary of China-based medical device company Andon Health, has received FDA clearance for a wireless fingertip pulse oximeter, which will be a distinct offering from the consumer pulse oximeter the company announced at CES last...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Projet professionnel
October 8, 2013 12:08 AM
Scoop.it!

Pourquoi il ne faut pas créer sa start-up dans la Silicon Valley

Pourquoi il ne faut pas créer sa start-up dans la Silicon Valley | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Les jeunes pousses percent rarement dans la Silicon Valley. Seules des sociétés françaises déjà matures peuvent espérer s'y développer avec succès.

Via Henri Lefèvre
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 7, 2013 5:19 PM
Scoop.it!

The Key Health-Care Trends Impacting Pharma

The Key Health-Care Trends Impacting Pharma | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Companies that can spot and capitalize on industry trends will enjoy long-term competitive advantages. So here’s a quick look around the corner.
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 7, 2013 4:39 PM
Scoop.it!

What is e-health?

What is e-health? | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
What is e-health?
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health Care Business
October 8, 2013 3:27 PM
Scoop.it!

The Future of Healthcare – Philips and Google Glass

The Future of Healthcare – Philips and Google Glass | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

Watch a demonstration of the future of healthcare. Learn about the proof of concept for IntelliVue Solutions built in conjunction with Accenture.

 

Today Philips and Accenture announced the creation of a proof-of-concept that uses a Google Glass head-mounted display for performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information. Additional ideas:

Accessing a near real-time feed of vital signs in Google Glass;Calling up images and other patient data by clinicians from anywhere in the hospital;Accessing a pre-surgery safety checklist;Giving clinicians the ability to view the patient in the recovery room after surgery;Conducting live, first-person point-of-view videoconferences with other surgeons or medical personnel; andRecording surgeries from a first-person point-of-view for training purposes.

This is interesting but proof of concepts have already been happening like the surgeons we covered in August.

See more here too: http://bit.ly/17dMH05


Via rob halkes
rob halkes's curator insight, October 8, 2013 10:22 AM

The bionic man in entering the arena of Health ;-)

Technology developments of care go quickly. I guess much more ado about real implementation and  trasnfer of benefits to patietns!

Rescooped by Lionel Reichardt / le Pharmageek from La pharma dans tous ses états
October 8, 2013 2:56 PM
Scoop.it!

3 Ways Med Tech Companies Can Create An Innovation Engine To Succeed In Healthcare

3 Ways Med Tech Companies Can Create An Innovation Engine To Succeed In Healthcare | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Med tech companies looking to succeed in new health economy that rewards better care must change how they innovate, finds PwC’s Health Research Institute.  The HRI report outlines how medtech companies need to expand their approaches to innovation...

Via Pharmacomptoir / Corinne Thuderoz
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Healthcare & Social Media
October 8, 2013 2:11 PM
Scoop.it!

Diagnostique : la santé connectée se porte plutôt bien | E-media, the Econocom blog

Diagnostique : la santé connectée se porte plutôt bien | E-media, the Econocom blog | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

Via Alexandre DUBOIS, Pharmacomptoir / Corinne Thuderoz
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Heart and Vascular Health
October 8, 2013 10:34 AM
Scoop.it!

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of microvascular complications than did those receiving conventional dietary therapy. We conducted post-trial monitoring to determine whether this improved glucose control persisted and whether such therapy had a long-term effect on macrovascular outcomes.

Results Between-group differences in glycated hemoglobin levels were lost after the first year. In the sulfonylurea–insulin group, relative reductions in risk persisted at 10 years for any diabetes-related end point (9%, P=0.04) and microvascular disease (24%, P=0.001), and risk reductions for myocardial infarction (15%, P=0.01) and death from any cause (13%, P=0.007) emerged over time, as more events occurred. In the metformin group, significant risk reductions persisted for any diabetes-related end point (21%, P=0.01), myocardial infarction (33%, P=0.005), and death from any cause (27%, P=0.002).

Conclusions

Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were observed during 10 years of post-trial follow-up. A continued benefit after metformin therapy was evident among overweight patients. (UKPDS 80; Current Controlled Trials number.


Via Seth Bilazarian, MD
Seth Bilazarian, MD's curator insight, October 8, 2013 9:36 AM

Amazing! Twenty five years ago the UKPDS published the follow-up of metformin in diabetes showing a benefit on heart attack and death even years after patients came off the drug.  Despite years of basic science and clinical research and billions of dollars spent on development of new therapies we still don't have a single other diabetes drug that reduces heart attack risk. Many drugs have been developed for blood sugar control but all have shown no benefit over placebo for reduction of heart attack risk for diabetics.  Only metformin.

Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 8:58 AM
Scoop.it!

Understanding the true audience will change the way you think about healthcare conferences

Understanding the true audience will change the way you think about healthcare conferences | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it

Not only is the number of people participating in the social conversation many times larger than the number of people physically present, but the number of links between these nodes is also exponentially larger, not to mention the number of people reached with these messages

No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 8:53 AM
Scoop.it!

dmdPost - Santé numérique : un modèle médico-économique encore à définir

dmdPost - Santé numérique : un modèle médico-économique encore à définir | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Le dernier Colloque Numérique et Santé qui s'est déroulé les 4 et 5 juillet derniers en atteste : le rapprochement entre les secteurs du numérique et...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:39 AM
Scoop.it!

The Right Ingredients for Innovation

The Right Ingredients for Innovation | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Innovation is crucial for growing a business in today's increasingly competitive global marketplace.
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:34 AM
Scoop.it!

Why the effective use of data is central to multichannel marketing

Why the effective use of data is central to multichannel marketing | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
The Festival of Marketing is but a day away and the Econsultancy office is a hot bed of activity as our events team rushes around making sure to tie up all loose ends before everything kicks off.
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:29 AM
Scoop.it!

Physicians Interactive, now a Merck GHI company, wants to be a comprehensive physician reader

Physicians Interactive, now a Merck GHI company, wants to be a comprehensive physician reader | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
Physicians Interactive, the digital health marketing company that offers medical content readers Skyscape and Omnio, was acquired in August by Merck’s Global Health Innovation Fund, which bought a controlling interest from former parent company...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 8, 2013 12:23 AM
Scoop.it!

Duke U. launches patient-centered medical homes with online tool coupling; ZocDoc founder says site gets 2.5M visits a month;

Duke U. launches patient-centered medical homes with online tool coupling; ZocDoc founder says site gets 2.5M visits a month; | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
News From Around the Web > The Duke University Health System has announced that they're using patient-centered medical homes and an online tool that will "help public health practitioners...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
October 7, 2013 5:22 PM
Scoop.it!

Top Five Components to Streamline Pharma Closed Loop Marketing

Top Five Components to Streamline Pharma Closed Loop Marketing | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it
eyeforpharma: As the pharma industry struggles to avoid being left behind, and technological advances happen at light speed, Daniel Cmardo, Senior Director of US Marketing Operations as Astellas, now offers a path forward.
No comment yet.